Shirey Kristin, Stover Kayla R, Cleary John, Hoang Ngoc, Hosler Jonathan
Department of Biochemistry and ‡School of Pharmacy, University of Mississippi Medical Center , 2500 North State Street, Jackson, Mississippi 39216, United States.
Biochemistry. 2016 Apr 12;55(14):2100-11. doi: 10.1021/acs.biochem.5b01368. Epub 2016 Mar 29.
The echinocandins are membrane-anchored, cyclic lipopeptides (CLPs) with antifungal activity due to their ability to inhibit a glucan synthase located in the plasma membrane of fungi such as Candida albicans. A hydrophobic tail of an echinocandin CLP inserts into a membrane, placing a six-amino acid cyclic peptide near the membrane surface. Because processes critical for the function of the electron transfer complexes of mitochondria, such as proton uptake and release, take place near the surface of the membrane, we have tested the ability of two echinocandin CLPs, caspofungin and micafungin, to affect the activity of electron transfer complexes in isolated mammalian mitochondria. Indeed, caspofungin and micafungin both inhibit whole chain electron transfer in isolated mitochondria at low micromolar concentrations. The effects of the CLPs are fully reversible, in some cases simply via the addition of bovine serum albumin to bind the CLPs via their hydrophobic tails. Each CLP affects more than one complex, but they still exhibit specificity of action. Only caspofungin inhibits complex I, and the CLP inhibits liver but not heart complex I. Both CLPs inhibit heart and liver complex III. Caspofungin inhibits complex IV activity, while, remarkably, micafungin stimulates complex IV activity nearly 3-fold. Using a variety of assays, we have developed initial hypotheses for the mechanisms by which caspofungin and micafungin alter the activities of complexes IV and III. The dication caspofungin partially inhibits cytochrome c binding at the low-affinity binding site of complex IV, while it also appears to inhibit the release of protons from the outer surface of the complex, similar to Zn(2+). Anionic micafungin appears to stimulate complex IV activity by enhancing the transfer of protons to the O2 reduction site. For complex III, we hypothesize that each CLP binds to the cytochrome b subunit and the Fe-S subunit to inhibit the required rotational movement of the latter.
棘白菌素是膜锚定的环状脂肽(CLP),具有抗真菌活性,因为它们能够抑制位于白色念珠菌等真菌质膜中的葡聚糖合酶。棘白菌素CLP的疏水尾部插入膜中,使一个六氨基酸环状肽靠近膜表面。由于线粒体电子传递复合物功能的关键过程,如质子摄取和释放,发生在膜表面附近,我们测试了两种棘白菌素CLP(卡泊芬净和米卡芬净)影响分离的哺乳动物线粒体中电子传递复合物活性的能力。事实上,卡泊芬净和米卡芬净在低微摩尔浓度下均能抑制分离线粒体中的全链电子传递。CLP的作用是完全可逆的,在某些情况下,只需添加牛血清白蛋白通过其疏水尾部结合CLP即可。每种CLP影响不止一种复合物,但它们仍表现出作用特异性。只有卡泊芬净抑制复合物I,且该CLP抑制肝脏而非心脏的复合物I。两种CLP均抑制心脏和肝脏的复合物III。卡泊芬净抑制复合物IV活性,而值得注意的是,米卡芬净将复合物IV活性刺激近3倍。通过各种测定,我们对卡泊芬净和米卡芬净改变复合物IV和III活性的机制提出了初步假设。二价阳离子卡泊芬净在复合物IV的低亲和力结合位点部分抑制细胞色素c结合,同时它似乎也抑制质子从复合物外表面释放,类似于Zn(2+)。阴离子米卡芬净似乎通过增强质子向O2还原位点的转移来刺激复合物IV活性。对于复合物III,我们假设每种CLP与细胞色素b亚基和Fe-S亚基结合,以抑制后者所需的旋转运动。